Wugen
Last updated: August 28, 2025

CEO - Kumar Srinivasan
USA | Funding: $172M (+)
Website: https://wugen.com/
Wugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies
Website: https://wugen.com/
Wugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies

